Reference
Nikolakis G, et al. Case Report: PsAPSASH syndrome: An alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab. F1000 Research 10: 381, Jan 2021. Available from: URL: http://f1000research.com/articles?tab=ALL&articleType=&subjectArea=&subtopic=&show=50
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1880, 18 (2021). https://doi.org/10.1007/s40278-021-04852-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-04852-2